Measurement of serotonin serum levels in cirrhotic patients as a new biomarker for the diagnosis of hepatocellular carcinoma
Al-Azhar Assiut Medical Journal · 2026-04 · 24 (2) · 332-337
DOI: 10.4103/azmj.azmj_2_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Al-Azhar Assiut Medical Journal, online erschienen am 08.07.2026. Verfasst von Mohammed B.M. Sofyan und 3 weiteren Autor:innen. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and aim The current gold standard for surveillance of Hepatocellular carcinoma (HCC) in Egypt, Alpha-fetoprotein (AFP), lacks sufficient sensitivity and specificity, often missing early-stage cases. Serotonin (5-hydroxytryptamine) is a potent mitogen involved in liver regeneration and angiogenesis. This study aimed to compare serum serotonin to AFP as a possible diagnostic biomarker for HCC in cirrhotic patients. Patients and methods A total of 90 individuals recruited from the Liver Center in Mahalla and Mansoura University Hospitals were enrolled in this study. Participants were divided into three groups: the first group (group I) comprised 30 patients diagnosed with cirrhosis and HCC, the second group (group II) comprised 30 patients diagnosed with cirrhosis but no HCC, and the third group (group III) comprised 30 apparently healthy individuals as controls. Laboratory investigations included liver and renal function tests, ANR, and complete blood count. Serum serotonin and AFP levels were assayed by ELISA. Results Serum serotonin and AFP levels showed a stepwise elevation from controls to cirrhotic patients to HCC patients ( P
Zitieren
APA
Sofyan, M. B., El-Bawab, E. M., Bakheet, M. S., & Mustafa, H. M. (2026). Measurement of serotonin serum levels in cirrhotic patients as a new biomarker for the diagnosis of hepatocellular carcinoma. Al-Azhar Assiut Medical Journal, 24(2), 332-337. https://doi.org/10.4103/azmj.azmj_2_26
Vancouver
Sofyan MB, El-Bawab EM, Bakheet MS, Mustafa HM. Measurement of serotonin serum levels in cirrhotic patients as a new biomarker for the diagnosis of hepatocellular carcinoma. Al-Azhar Assiut Medical Journal. 2026;24(2):332-337. doi:10.4103/azmj.azmj_2_26
BibTeX
@article{Sofyan2026,
author = {Sofyan, Mohammed B.M. and El-Bawab, El-Said M. and Bakheet, Mohammad S.A. and Mustafa, Hamdy M.},
title = {Measurement of serotonin serum levels in cirrhotic patients as a new biomarker for the diagnosis of hepatocellular carcinoma},
journal = {Al-Azhar Assiut Medical Journal},
year = {2026},
volume = {24},
number = {2},
pages = {332--337},
doi = {10.4103/azmj.azmj_2_26}
}
EUVIMED